EMvision Medical Devices (ASX:EMV) Other Current Liabilities: A$0.87 Mil (As of Dec. 2025)


ASX:EMV EMvision Medical Devices Ltd ASX:EMV
31 GF Score
Price A$1.55
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices Other Current Liabilities?

EMvision Medical Devices ASX:EMV -0.96% 31 Other Current Liabilities is A$0.87 Mil as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

EMvision Medical Devices's other current liabilities for the quarter that ended in Dec. 2025 was A$0.87 Mil.

EMvision Medical Devices's quarterly other current liabilities increased from Dec. 2024 (A$0.94 Mil) to Jun. 2025 (A$1.31 Mil) but then declined from Jun. 2025 (A$1.31 Mil) to Dec. 2025 (A$0.87 Mil).

EMvision Medical Devices's annual other current liabilities declined from Jun. 2023 (A$2.61 Mil) to Jun. 2024 (A$1.42 Mil) and declined from Jun. 2024 (A$1.42 Mil) to Jun. 2025 (A$1.31 Mil).


EMvision Medical Devices Other Current Liabilities Related Terms


EMvision Medical Devices Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for EMvision Medical Devices's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices Other Current Liabilities Chart

EMvision Medical Devices Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Current Liabilities
Get a 7-Day Free Trial 0.16 0.27 2.61 1.42 1.31

EMvision Medical Devices Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.68 1.42 0.94 1.31 0.87
ASX:EMV
31GF Score
EMvision Medical Devices Ltd ASX:EMV
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EMvision Medical Devices Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of A$0.87 Mil mean?
EMvision Medical Devices (ASX:EMV) has a Other Current Liabilities of A$0.87 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on EMvision Medical Devices.
Is EMvision Medical Devices' Other Current Liabilities too high?
EMvision Medical Devices' current Other Current Liabilities is A$0.87 Mil. Overall, EMvision Medical Devices has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' Other Current Liabilities compare to ABT and SYK?
EMvision Medical Devices' Other Current Liabilities of A$0.87 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on EMvision Medical Devices. EMvision Medical Devices's current Other Current Liabilities is A$0.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current Other Current Liabilities of A$0.87 Mil. The current Other Current Liabilities is A$0.87 Mil. EMvision Medical Devices' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current Other Current Liabilities is A$0.87 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
31GF Score

Get the complete analysis for ASX:EMV

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.55
Price